Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853 |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 |
Methods | qPCR, RNAi, Western blot, ChIP, Cell proliferation assay etc. |
Sample | HCC tissues, cell lines (HepG2, SMMC-7721, Bel-7402, MHCC97H, and HCC-LM3) |
Expression Pattern | up-regulated |
Function Description | In addition, hypoxia-inducible factor (HIF)-2a is up-regulated in HCCs, and MALAT1 and HIF-2a have a positive correlation in HCC tissues. During the malignant transformation of human hepatic epithelial (L-02) cells induced by a low concentration (2.0 ?M) of arsenite, MALAT1 and HIF-2a are increased. In addition, arsenite-induced MALAT1 causes disassociation of the von Hippel-Lindau (VHL) protein from HIF-2a, therefore, alleviating VHL-mediated HIF-2a ubiquitination, which causes HIF-2a accumulation. In turn, HIF-2a transcriptionally regulates MALAT1, thus forming a positive feedback loop to ensure expression of arsenite-induced MALAT1 and HIF-2a, which are involved in malignant transformation. Moreover, MALAT1 and HIF-2a promote the invasive and metastatic capacities of arsenite-induced transformed L-02 cells and in HCC-LM3 cells. |
Pubmed ID | 26735578 |
Year | 2016 |
Title | A MALAT1/HIF-2a feedback loop contributes to arsenite carcinogenesis. |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for hepatocellular carcinoma | OMIM COSMIC |